4.5 Article

Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Rational combinations of targeted cancer therapies: background, advances and challenges

Haojie Jin et al.

Summary: In the past two decades, advancements in understanding the genetic defects underlying cancer have led to the development of numerous targeted cancer drugs. However, resistance to single-agent therapies remains a major hurdle. Rational drug combinations based on a deep understanding of the molecular mechanisms associated with therapy resistance hold great potential in cancer treatment. This article discusses the mechanisms of resistance to targeted therapies and the identification of effective drug combinations to overcome resistance, as well as the challenges in clinically developing these combinations and future perspectives.

NATURE REVIEWS DRUG DISCOVERY (2023)

Article Pharmacology & Pharmacy

Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke

Zexuan Hong et al.

Summary: Stroke is a major cause of death, with oxidative stress playing a key role. Celastrol has strong antioxidant properties, but its effect on oxidative reactions in cerebral ischemic-reperfusion injury (CIRI) is unclear. This study aimed to investigate the impact of celastrol on oxidative damage during CIRI and the underlying mechanisms. The findings revealed that celastrol reduced oxidative injury in CIRI by upregulating Nrf2. Celastrol directly bound to Nedd4, releasing Nrf2 in astrocytes, thus inhibiting Nrf2 degradation and reducing astrocytic ROS production. Celastrol also rescued neurons from damage and apoptosis by inhibiting oxidative stress and astrocyte activation.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2023)

Review Oncology

Targeting drugs to tumours using cell membrane-coated nanoparticles

Ronnie H. Fang et al.

Summary: Cell membrane-coated nanoparticles (CNPs) are emerging nanocarriers that have the potential to improve cancer therapy by overcoming limitations of traditional nanoparticles. CNPs, consisting of a synthetic nanoparticulate core surrounded by a layer of naturally derived cell membranes, offer improved biocompatibility, immune evasion, and tumor targeting. They have been used for drug delivery, phototherapy, and immunotherapy.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Article Multidisciplinary Sciences

Continuous Spatiotemporal Therapy of A Full-API Nanodrug via Multi-Step Tandem Endogenous Biosynthesis

Fang Fang et al.

Summary: This study reports a full-API nanodrug with an ideal API content and pH-responsive release for continuous spatiotemporal cancer therapy based on the PpIX-heme-CO/Fe2+/BV-BR metabolic pathway. It provides a paradigm for tumor suppression using diversified metabolites and facilitates the practical translation of nanodrugs.

NATURE COMMUNICATIONS (2023)

Review Engineering, Environmental

Metal-coordinated nanodrugs based on natural products for cancer theranostics

Shuang Liu et al.

Summary: Metal-coordinated nanodrugs based on natural products have garnered widespread attention in cancer theranostics. Natural products possess unparalleled advantages such as abundant active groups, easy modification/functionalization, low cost, unique pharmacological activity, and good biocompatibility. Furthermore, the active groups on natural products can coordinate with various metal ions to construct metal-coordinated nanodrugs. These nanodrugs offer multifunctional cancer theranostic platforms with facile and green preparation methods, optimized structures and properties, stable blood circulation, and responsiveness to the tumor microenvironment.

CHEMICAL ENGINEERING JOURNAL (2023)

Article Biochemistry & Molecular Biology

Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1

Heng Xu et al.

Summary: In this study, a text-mining-based web-server tool was developed to identify the target protein of Celastrol in colorectal cancer. PRDX1 was identified as the target, and a new derivative compound 19-048 with improved potency against PRDX1 was synthesized. Both Celastrol and 19-048 showed anti-tumor efficacy in colorectal cancer cells and in a mouse model. Structural modification of Celastrol could reduce its side effects, and inhibition of PRDX1 holds promise for colorectal cancer treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Chemistry, Multidisciplinary

Enhanced Chemodynamic Therapy by Cu-Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction

Sagang Koo et al.

Summary: The study presents a heterogeneous chemodynamic therapy (CDT) system based on copper-iron peroxide nanoparticles for synergistic therapy in the tumor microenvironment (TME). The system demonstrates excellent tumor therapeutic efficacy by enhancing hydroxyl radical production through a highly efficient catalytic loop. It also generates O-2 and exhibits TME-responsive T-1 magnetic resonance imaging contrast enhancement.

ACS NANO (2022)

Article Chemistry, Multidisciplinary

Two-dimensional coordination polymer-based nanosensor for sensitive and reliable nucleic acids detection in living cells

Yuzhi Xu et al.

Summary: Researchers have developed a facile method to synthesize two-dimensional coordination polymer nanosheets for nucleic acid detection. These nanosheets can be used as nanosensors with low detection limits and can also deliver nucleic acids.

CHINESE CHEMICAL LETTERS (2022)

Review Materials Science, Multidisciplinary

Carrier-free nanomedicines for cancer treatment

Li-Han Liu et al.

Summary: The past decade has seen significant advances in the development of carrier-free nanomedicines, which are attractive due to their high biosafety, drug loading capacities, simple compositions, and simplified synthesis procedures. Extensive efforts have been made to expand the scope of carrier-free nanomedicines and improve their therapeutic performance through the exploration of new excipients, therapeutic agents, self-assembly methods, and mechanisms. This review summarizes the research progress and practical applications of carrier-free nanomedicines in cancer therapy.

PROGRESS IN MATERIALS SCIENCE (2022)

Article Pharmacology & Pharmacy

Cooperative coordination-mediated multi-component self-assembly of ?all-in-one? nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer

Xiaojie Chen et al.

Summary: Carrier-free multi-component self-assembled nano-systems have shown great potential in breast cancer treatment. The MnAs-ICG nanospike, generated by self-assembly of ICG, Mn2+ ions, and AsO43-, exhibits excellent therapeutic efficacy and imaging ability for photothermal/chemo/chemodynamic therapy.

ACTA PHARMACEUTICA SINICA B (2022)

Article Chemistry, Multidisciplinary

Tumor Response and NIR-II Photonic Thermal Co-Enhanced Catalytic Therapy Based on Single-Atom Manganese Nanozyme

Jin Ye et al.

Summary: Single-atom nanozymes have great potential to replace natural enzymes by mimicking their metal active centers at the atomic level. A PEGylated mesoporous Mn-based single-atom nanozyme has been designed, exhibiting excellent enzymatic performance and photothermal conversion efficiency. It can effectively kill cancer cells through catalytic and photothermal therapy.

ADVANCED FUNCTIONAL MATERIALS (2022)

Article Pharmacology & Pharmacy

Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors

Geer Chen et al.

Summary: Alterations in histone modification have been shown to be related to cancer development and progression. Celastrol, a Chinese herbal compound, exhibits potent anti-tumor effects through multiple signaling pathways. This study demonstrates that histone modifications, especially histone acetylation associated with the NuA4 histone acetyltransferase complex, are involved in the anti-proliferation actions of celastrol. Combination therapy with celastrol and histone deacetylase inhibitors (HDACi) synergistically suppresses cancer cell proliferation. The results suggest that the combination of celastrol and HDACi could be a potential novel therapeutic approach for lung cancer patients.

PHARMACOLOGICAL RESEARCH (2022)

Review Chemistry, Multidisciplinary

Carrier-free nanodrugs for safe and effective cancer treatment

Sena Karaosmanoglu et al.

Summary: The clinical applications of many anti-cancer drugs are limited by their hydrophobic nature, leading to the development of carrier-based nanoparticles. However, these strategies often fail to efficiently encapsulate drugs and may cause toxicity problems in the long term. Therefore, elegantly designed strategies for carrier-free nanodrugs, including simple self-assembly and chemical modifications, are desired for high quality, stability, and performance.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Chemistry, Multidisciplinary

Biomedicine Meets Fenton Chemistry

Zhongmin Tang et al.

Summary: This review provides a comprehensive overview of the importance and representative applications of Fenton chemistry in the field of biomedicine, as well as future directions for development, which is essential for further advancement in this field.

CHEMICAL REVIEWS (2021)

Review Chemistry, Inorganic & Nuclear

ROS-based dynamic therapy synergy with modulating tumor cell-microenvironment mediated by inorganic nanomedicine

Xiaoyan Zhong et al.

Summary: Dynamic therapy (DT) by in situ ROS generation using inorganic nanomaterials-based nanomedicine is a promising approach for deep-seated tumor treatment. Various strategies to modulate the tumor cell microenvironment are discussed for enhancing the efficacy of DT in this comprehensive review.

COORDINATION CHEMISTRY REVIEWS (2021)

Article Chemistry, Multidisciplinary

Dynamic Behavior of Single-Atom Catalysts in Electrocatalysis: Identification of Cu-N-3 as an Active Site for the Oxygen Reduction Reaction

Ji Yang et al.

Summary: Atomically dispersed Cu-N-C single-atom catalysts with Cu2+-N-4 structure exhibit comparable activity and superior durability to Pt/C in the electrochemical reduction of oxygen. The dynamic evolution of Cu-N-4 to Cu-N-3 and further to HO-Cu-N-2 under ORR conditions is identified, with the low-coordinated Cu+-N-3 being determined as the real active site. The findings may guide the design of more efficient low-cost catalysts.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Chemistry, Multidisciplinary

Metal-Coordinated Supramolecular Self-Assemblies for Cancer Theranostics

Jiating Xu et al.

Summary: Metal-coordinated supramolecular nanoassemblies have unique physicochemical properties that bridge the boundary between traditional inorganic and organic materials, making them promising for cancer theranostics. By tailoring the structural components, multifunctional theranostic nanomedicines can be constructed to modulate the tumor microenvironment and enhance tumor accumulation. The advancements in design and fabrication, as well as the prospects and challenges of metal-coordinated supramolecular self-assemblies for technical advances and clinical translation, are discussed.

ADVANCED SCIENCE (2021)

Review Chemistry, Medicinal

Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology

Wei Hou et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Chemistry, Multidisciplinary

Recent progress of chemodynamic therapy-induced combination cancer therapy

Xianwen Wang et al.

NANO TODAY (2020)

Article Biochemistry & Molecular Biology

IL1R1 is required for celastrol's leptin-sensitization and antiobesity effects

Xudong Feng et al.

NATURE MEDICINE (2019)

Article Pharmacology & Pharmacy

Integrated metabolomics and network toxicology to reveal molecular mechanism of celastrol induced cardiotoxicity

Chuanxin Liu et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Article Multidisciplinary Sciences

Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer

Jutaek Nam et al.

NATURE COMMUNICATIONS (2018)

Article Pharmacology & Pharmacy

Celastrol as a pentacyclic triterpenoid with chemopreventive properties

Priya Yadav et al.

PHARMACEUTICAL PATENT ANALYST (2018)

Review Oncology

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Tsukasa Shibue et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Formulation and Evaluation of Celastrol-Loaded Liposomes

Jie Song et al.

MOLECULES (2011)